XML 25 R7.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Jan. 31, 2019
Jan. 31, 2018
Cash flows from operating activities:    
Net income $ 54,169 $ 93,588
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 34,490 36,881
Stock-based compensation expense 18,028 15,800
Impairment of tradenames 106,555  
Provision for doubtful accounts 11,012 9,933
Gain on cash surrender value of life insurance policies (4,547) (6,020)
Gain on marketable securities (1,330) (14,022)
Deferred income taxes (23,192) 5,373
Change in other assets and liabilities:    
Deferred compensation 5,486 25,587
Receivables due from clients (44,332) (62,464)
Income taxes and other receivables (1,142) 4,445
Prepaid expenses and other assets (479) (1,201)
Unearned compensation (15,097) (42,904)
Investment in unconsolidated subsidiaries (191) (187)
Income taxes payable (532) 18,217
Accounts payable and accrued liabilities (33,076) (15,569)
Other (4,865) (7,865)
Net cash provided by operating activities 100,957 59,592
Cash flows from investing activities:    
Purchase of property and equipment (36,886) (31,133)
Purchase of marketable securities (8,672) (7,462)
Proceeds from sales/maturities of marketable securities 13,557 2,515
Premium on company-owned life insurance policies (34,612) (1,339)
Dividends received from unconsolidated subsidiaries 140 60
Proceeds from life insurance policies 6,972 5,175
Net cash used in investing activities (59,501) (32,184)
Cash flows from financing activities:    
Proceeds from long term debt 226,875  
Principal payments on term loan (238,906) (15,469)
Payment of debt issuance costs (2,181)  
Payment of contingent consideration from acquisitions (455) (485)
Repurchases of common stock (37,372) (32,568)
Payments of tax withholdings on restricted stock (20,497) (3,657)
Proceeds from issuance of common stock upon exercise of employee stock options and in connection with an employee stock purchase plan 7,271 6,885
Dividends paid to shareholders (17,758) (17,242)
Dividends - noncontrolling interest (2,255) (1,558)
Borrowings under life insurance policies 31,870  
Payments on life insurance policy loans (4,351) (464)
Net cash used in financing activities (57,759) (64,558)
Effect of exchange rate changes on cash and cash equivalents (15,036) 16,258
Net decrease in cash and cash equivalents (31,339) (20,892)
Cash and cash equivalents at beginning of period 520,848 410,882
Cash and cash equivalents at end of the period $ 489,509 $ 389,990